Literature DB >> 20578959

Paraoxonase 2 deficiency alters mitochondrial function and exacerbates the development of atherosclerosis.

Asokan Devarajan1, Noam Bourquard, Susan Hama, Mohamad Navab, Victor R Grijalva, Susan Morvardi, Catherine F Clarke, Laurent Vergnes, Karen Reue, John F Teiber, Srinivasa T Reddy.   

Abstract

Increased production of reactive oxygen species (ROS) as a result of decreased activities of mitochondrial electron transport chain (ETC) complexes plays a role in the development of many inflammatory diseases, including atherosclerosis. Our previous studies established that paraoxonase 2 (PON2) possesses antiatherogenic properties and is associated with lower ROS levels. The aim of the present study was to determine the mechanism by which PON2 modulates ROS production. In this report, we demonstrate that PON2-def mice on the hyperlipidemic apolipoprotein E(-/-) background (PON2-def/apolipoprotein E(-/-)) develop exacerbated atherosclerotic lesions with enhanced mitochondrial oxidative stress. We show that PON2 protein is localized to the inner mitochondrial membrane, where it is found associated with respiratory complex III. Employing surface-plasmon-resonance, we demonstrate that PON2 binds with high affinity to coenzyme Q(10), an important component of the ETC. Enhanced mitochondrial oxidative stress in PON2-def mice was accompanied by significantly reduced ETC complex I + III activities, oxygen consumption, and adenosine triphosphate levels in PON2-def mice. In contrast, overexpression of PON2 effectively protected mitochondria from antimycin- or oligomycin-mediated mitochondrial dysfunction. Our results illustrate that the antiatherogenic effects of PON2 are, in part, mediated by the role of PON2 in mitochondrial function.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20578959      PMCID: PMC3011913          DOI: 10.1089/ars.2010.3430

Source DB:  PubMed          Journal:  Antioxid Redox Signal        ISSN: 1523-0864            Impact factor:   8.401


  32 in total

Review 1.  Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver-derived tissues.

Authors:  P L Pedersen; J W Greenawalt; B Reynafarje; J Hullihen; G L Decker; J W Soper; E Bustamente
Journal:  Methods Cell Biol       Date:  1978       Impact factor: 1.441

2.  Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.

Authors:  R K Tangirala; E M Rubin; W Palinski
Journal:  J Lipid Res       Date:  1995-11       Impact factor: 5.922

3.  A high diffusion coefficient for coenzyme Q10 might be related to a folded structure.

Authors:  S Di Bernardo; R Fato; R Casadio; P Fariselli; G Lenaz
Journal:  FEBS Lett       Date:  1998-04-10       Impact factor: 4.124

4.  Mitochondrial function is involved in LDL oxidation mediated by human cultured endothelial cells.

Authors:  L Mabile; O Meilhac; I Escargueil-Blanc; M Troly; M T Pieraggi; R Salvayre; A Nègre-Salvayre
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-08       Impact factor: 8.311

5.  Differential effects of antimycin on ubisemiquinone bound in different environments in isolated succinate . cytochrome c reductase complex.

Authors:  T Ohnishi; B L Trumpower
Journal:  J Biol Chem       Date:  1980-04-25       Impact factor: 5.157

6.  Comparisons of coenzyme Q bound to mitochondrial membrane proteins among different mammalian species.

Authors:  A Lass; R S Sohal
Journal:  Free Radic Biol Med       Date:  1999-07       Impact factor: 7.376

7.  Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria.

Authors:  J F Turrens; A Alexandre; A L Lehninger
Journal:  Arch Biochem Biophys       Date:  1985-03       Impact factor: 4.013

8.  Oligomycin sensitivity of mitochondrial F(1)F(0)-ATPase in diabetes-prone BHE/Cdb rats.

Authors:  S B Kim; C D Berdanier
Journal:  Am J Physiol       Date:  1999-10

9.  Calcineurin transgenic mice have mitochondrial dysfunction and elevated superoxide production.

Authors:  M R Sayen; Asa B Gustafsson; Mark A Sussman; Jeffery D Molkentin; Roberta A Gottlieb
Journal:  Am J Physiol Cell Physiol       Date:  2002-10-23       Impact factor: 4.249

Review 10.  Oxidized lipids as mediators of coronary heart disease.

Authors:  Mohamad Navab; Susan Y Hama; Srinu T Reddy; Carey J Ng; Brian J Van Lenten; Hillel Laks; Alan M Fogelman; Srinu T Ready
Journal:  Curr Opin Lipidol       Date:  2002-08       Impact factor: 4.776

View more
  76 in total

1.  Paraoxonase-2 modulates stress response of endothelial cells to oxidized phospholipids and a bacterial quorum-sensing molecule.

Authors:  Juyong Brian Kim; Yu-Rong Xia; Casey E Romanoski; Sangderk Lee; YongHong Meng; Yi-Shou Shi; Noam Bourquard; Ke Wei Gong; Zachary Port; Victor Grijalva; Srinivasa T Reddy; Judith A Berliner; Aldons J Lusis; Diana M Shih
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-11       Impact factor: 8.311

Review 2.  Paraoxonase-2 (PON2) in brain and its potential role in neuroprotection.

Authors:  Lucio G Costa; Rian de Laat; Khoi Dao; Claudia Pellacani; Toby B Cole; Clement E Furlong
Journal:  Neurotoxicology       Date:  2013-09-04       Impact factor: 4.294

Review 3.  Reactive Oxygen Species in Metabolic and Inflammatory Signaling.

Authors:  Steven J Forrester; Daniel S Kikuchi; Marina S Hernandes; Qian Xu; Kathy K Griendling
Journal:  Circ Res       Date:  2018-03-16       Impact factor: 17.367

4.  Paraoxonase 2 (PON2) in the mouse central nervous system: a neuroprotective role?

Authors:  Gennaro Giordano; Toby B Cole; Clement E Furlong; Lucio G Costa
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-23       Impact factor: 4.219

5.  PON3 is upregulated in cancer tissues and protects against mitochondrial superoxide-mediated cell death.

Authors:  E-M Schweikert; A Devarajan; I Witte; P Wilgenbus; J Amort; U Förstermann; A Shabazian; V Grijalva; D M Shih; R Farias-Eisner; J F Teiber; S T Reddy; S Horke
Journal:  Cell Death Differ       Date:  2012-03-23       Impact factor: 15.828

6.  Paraoxonases-1, -2 and -3: What are their functions?

Authors:  Clement E Furlong; Judit Marsillach; Gail P Jarvik; Lucio G Costa
Journal:  Chem Biol Interact       Date:  2016-05-26       Impact factor: 5.192

7.  Paraoxonase 2 serves a proapopotic function in mouse and human cells in response to the Pseudomonas aeruginosa quorum-sensing molecule N-(3-Oxododecanoyl)-homoserine lactone.

Authors:  Christian Schwarzer; Zhu Fu; Takeshi Morita; Aaron G Whitt; Aaron M Neely; Chi Li; Terry E Machen
Journal:  J Biol Chem       Date:  2015-01-27       Impact factor: 5.157

8.  Paraoxonase 2 prevents the development of heart failure.

Authors:  Wei Li; David Kennedy; Zhili Shao; Xi Wang; Andre Klaassen Kamdar; Malory Weber; Kayla Mislick; Kathryn Kiefer; Rommel Morales; Brendan Agatisa-Boyle; Diana M Shih; Srinivasa T Reddy; Christine S Moravec; W H Wilson Tang
Journal:  Free Radic Biol Med       Date:  2018-05-02       Impact factor: 7.376

9.  Paraoxonase 1 L55M, Q192R and paraoxonase 2 S311C alleles in atherothrombosis.

Authors:  L Cozzi; J Campolo; M Parolini; R De Maria; M C Patrosso; A Marocchi; O Parodi; S Penco
Journal:  Mol Cell Biochem       Date:  2012-12-06       Impact factor: 3.396

Review 10.  Redox signaling in cardiovascular health and disease.

Authors:  Nageswara R Madamanchi; Marschall S Runge
Journal:  Free Radic Biol Med       Date:  2013-04-11       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.